Choline metabolism in ischemic stroke: An underappreciated "two-edged sword"

Pharmacol Res. 2025 Apr:214:107685. doi: 10.1016/j.phrs.2025.107685. Epub 2025 Mar 5.

Abstract

Ischemic stroke (IS) is an important cause of death and disability worldwide, but the molecular mechanisms involved are not fully understood. In this context, choline metabolism plays an increasingly important role in IS due to its multifaceted mechanisms involving neuroprotection, neuroregeneration, inflammatory response, immune regulation, and long-term health effects. With the deepening of the research on choline and its metabolites, such as trimethylamine-N-oxide (TMAO), scientists have gradually realized its key role in the occurrence, development and potential treatment of IS. This review summarizes the importance of choline in neuroprotection and long-term disease management, highlighting the complexity of choline metabolism affecting cerebrovascular health through gut microbes. Although choline and its metabolites exhibit a protective effect, excessive intake and increases in some metabolites may confer risk, suggesting the need to carefully balance dietary choline intake. The purpose of this review is to integrate the existing research results and provide a theoretical basis for further exploring the mechanism, prognosis evaluation and clinical intervention of choline metabolism in ischemic IS, hoping to provide a new perspective and enlightenment for the formulation of effective stroke prevention and treatment strategies, and promote a comprehensive understanding of heart and brain health and optimize intervention methods.

Keywords: Acetylcholine; Choline metabolism; Citicoline; Ischemic stroke; Phosphatidylcholine; TMAO.

Publication types

  • Review

MeSH terms

  • Animals
  • Brain* / drug effects
  • Brain* / metabolism
  • Choline* / metabolism
  • Gastrointestinal Microbiome
  • Humans
  • Ischemic Stroke* / metabolism

Substances

  • Choline